INS and Hyperglycemia: In the STZ diabetic animal models, the plasma level of insulin is declined remarkably after a single high dose of STZ administered with intraperitoneal injection that induces severe symptoms of diabetes, such as hyperglycemia, hyperphagia, polydipsia and polyuria; however, it has a high level of mortality rate [10].